1. Home
  2. EPAC vs NVAX Comparison

EPAC vs NVAX Comparison

Compare EPAC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPAC
  • NVAX
  • Stock Information
  • Founded
  • EPAC 1910
  • NVAX 1987
  • Country
  • EPAC United States
  • NVAX United States
  • Employees
  • EPAC N/A
  • NVAX N/A
  • Industry
  • EPAC Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPAC Technology
  • NVAX Health Care
  • Exchange
  • EPAC Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • EPAC 2.3B
  • NVAX 1.3B
  • IPO Year
  • EPAC N/A
  • NVAX 1995
  • Fundamental
  • Price
  • EPAC $40.66
  • NVAX $6.38
  • Analyst Decision
  • EPAC Buy
  • NVAX Buy
  • Analyst Count
  • EPAC 1
  • NVAX 5
  • Target Price
  • EPAC $53.00
  • NVAX $16.60
  • AVG Volume (30 Days)
  • EPAC 325.7K
  • NVAX 5.5M
  • Earning Date
  • EPAC 06-26-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • EPAC 0.10%
  • NVAX N/A
  • EPS Growth
  • EPAC 7.49
  • NVAX N/A
  • EPS
  • EPAC 1.63
  • NVAX 2.97
  • Revenue
  • EPAC $608,099,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • EPAC $5.94
  • NVAX $56.85
  • Revenue Next Year
  • EPAC $5.78
  • NVAX N/A
  • P/E Ratio
  • EPAC $25.79
  • NVAX $2.12
  • Revenue Growth
  • EPAC 2.82
  • NVAX 25.92
  • 52 Week Low
  • EPAC $36.78
  • NVAX $5.01
  • 52 Week High
  • EPAC $51.91
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • EPAC 59.34
  • NVAX 44.45
  • Support Level
  • EPAC $41.80
  • NVAX $6.26
  • Resistance Level
  • EPAC $43.49
  • NVAX $6.66
  • Average True Range (ATR)
  • EPAC 0.69
  • NVAX 0.33
  • MACD
  • EPAC 0.10
  • NVAX -0.08
  • Stochastic Oscillator
  • EPAC 99.19
  • NVAX 22.16

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: